Abstract
In Spring 2020, the United States epicenter of COVID-19 was New York City, in which the borough of the Bronx was particularly affected. This Fall, there has been a resurgence of COVID-19 in Europe and the Midwestern United States. We describe our experience transforming our cardiac catheterization laboratories to accommodate an influx of COVID-19 patients so as to provide other hospitals with a potential blueprint. We transformed our pre/postprocedural patient care areas into COVID-19 intensive care and step-down units and maintained emergent invasive care for ST-segment elevation myocardial infarction using existing space and personnel.
Keywords:
COVID-19; SARS-CoV-2; cardiac; catheterization.
MeSH terms
-
COVID-19* / epidemiology
-
COVID-19* / therapy
-
Cardiac Catheterization / methods*
-
Cardiology Service, Hospital* / organization & administration
-
Cardiology Service, Hospital* / trends
-
Coronary Care Units* / methods
-
Coronary Care Units* / organization & administration
-
Critical Care* / methods
-
Critical Care* / organization & administration
-
Critical Care* / trends
-
Humans
-
Infection Control* / methods
-
Infection Control* / organization & administration
-
Laboratories, Hospital / organization & administration*
-
New York City / epidemiology
-
Organizational Innovation*
-
Patient Care Team / organization & administration
-
Perioperative Care / methods
-
SARS-CoV-2
-
ST Elevation Myocardial Infarction* / epidemiology
-
ST Elevation Myocardial Infarction* / therapy